Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. (2022)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41564-022-01241-6
PubMed Identifier: 36114232
Publication URI: http://europepmc.org/abstract/MED/36114232
Type: Journal Article/Review
Volume: 7
Parent Publication: Nature microbiology
Issue: 10
ISSN: 2058-5276